Anuh Pharma intimates of suspension of Pyrazinamide and Sulfadoxine from the WHO list of prequalified APIs

Following EDQM suspension

Anuh Pharma announced that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxine from the WHO list of prequalified APIs until the WHO led inspection.

Powered by Capital Market - Live News